PLTP deficiency-mediated atherosclerosis regression could be related to sphinogosine-1-phosphate reduction.
作者信息
Zheng Jiao, Zhang Ke, Li Zhiqiang, Worgall Tilla S, Jiang Xian-Cheng
机构信息
SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
出版信息
Atherosclerosis. 2022 Sep;356:53-55. doi: 10.1016/j.atherosclerosis.2022.07.007. Epub 2022 Jul 15.
Abstract
摘要
相似文献
1
PLTP deficiency-mediated atherosclerosis regression could be related to sphinogosine-1-phosphate reduction.
Atherosclerosis. 2022 Sep;356:53-55. doi: 10.1016/j.atherosclerosis.2022.07.007. Epub 2022 Jul 15.
2
Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):578-86. doi: 10.1161/01.ATV.0000254815.49414.be. Epub 2006 Dec 14.
3
Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):190-6. doi: 10.1161/01.ATV.0000249721.96666.e5. Epub 2006 Oct 12.
4
Inducible phospholipid transfer protein deficiency ameliorates atherosclerosis.
Atherosclerosis. 2021 May;324:9-17. doi: 10.1016/j.atherosclerosis.2021.03.011. Epub 2021 Mar 13.
5
The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis.
Curr Atheroscler Rep. 2021 Jan 26;23(3):9. doi: 10.1007/s11883-021-00907-6.
6
Disruption of Phospholipid Transfer Protein-Mediated High-Density Lipoprotein Maturation Reduces Scavenger Receptor BI Deficiency-Driven Atherosclerosis Susceptibility Despite Unexpected Metabolic Complications.
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):611-623. doi: 10.1161/ATVBAHA.119.313862. Epub 2020 Jan 16.
7
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1572-8. doi: 10.1161/01.ATV.0000225700.43836.ae. Epub 2006 May 4.
8
Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability.
Lipids. 2014 Feb;49(2):183-90. doi: 10.1007/s11745-013-3850-y. Epub 2013 Oct 25.
9
Phospholipid transfer protein destabilizes mouse atherosclerotic plaque.
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2537-44. doi: 10.1161/ATVBAHA.114.303966. Epub 2014 Oct 16.
10
Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2058-64. doi: 10.1161/ATVBAHA.113.301628. Epub 2013 Jul 11.
引用本文的文献
1
Proteomic analysis of human follicular fluid based on the 4D label free method to identify proteins that may affect oocyte quality in hyperandrogenic PCOS patients.
Front Endocrinol (Lausanne). 2025 May 15;16:1579469. doi: 10.3389/fendo.2025.1579469. eCollection 2025.
2
Sphingosine 1-phosphate receptor 1signaling in macrophages reduces atherosclerosis in LDL receptor-deficient mice.
JCI Insight. 2024 Dec 20;9(24):e158127. doi: 10.1172/jci.insight.158127.
3
Effect of phospholipid transfer protein on plasma sphingosine-1-phosphate.
J Biol Chem. 2024 Nov;300(11):107837. doi: 10.1016/j.jbc.2024.107837. Epub 2024 Sep 27.
本文引用的文献
1
Inducible phospholipid transfer protein deficiency ameliorates atherosclerosis.
Atherosclerosis. 2021 May;324:9-17. doi: 10.1016/j.atherosclerosis.2021.03.011. Epub 2021 Mar 13.
2
Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.
J Lipid Res. 2019 Nov;60(11):1912-1921. doi: 10.1194/jlr.RA119000277. Epub 2019 Aug 28.
3
Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater.
Front Immunol. 2019 Jul 19;10:1706. doi: 10.3389/fimmu.2019.01706. eCollection 2019.
4
Sphingosine 1-phosphate and inflammation.
Int Immunol. 2019 Aug 23;31(9):617-625. doi: 10.1093/intimm/dxz037.
5
Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis.
Front Immunol. 2018 Dec 19;9:2980. doi: 10.3389/fimmu.2018.02980. eCollection 2018.
6
Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets.
Nature. 2017 Oct 26;550(7677):524-528. doi: 10.1038/nature24053. Epub 2017 Oct 18.
7
Effects of apolipoprotein M in uremic atherosclerosis.
Atherosclerosis. 2017 Oct;265:93-101. doi: 10.1016/j.atherosclerosis.2017.08.005. Epub 2017 Aug 18.
8
Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
J Lipid Res. 2017 Apr;58(4):731-741. doi: 10.1194/jlr.M074625. Epub 2017 Jan 30.
9
Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back.
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):226-35. doi: 10.1161/ATVBAHA.115.301926. Epub 2015 Dec 17.
10
Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability.
Lipids. 2014 Feb;49(2):183-90. doi: 10.1007/s11745-013-3850-y. Epub 2013 Oct 25.
Zotero 插件